Integrated Pharmacy (IP) 1 Drug Discovery & Development Practice Exam 2026 - Free Pharmacy Practice Questions and Study Guide

Post-marketing safety surveillance is conducted after a drug is approved to identify long-term and rare adverse effects in the general population. This is the phase that focuses on post-marketing safety and real-world effectiveness, often through pharmacovigilance activities, safety monitoring, and sometimes additional studies to assess new indications or dosing in diverse patient groups. The earlier phases build safety and efficacy data in controlled, smaller populations: Phase I explores safety and dosing, Phase II looks at initial efficacy and safety in patients, and Phase III confirms efficacy and safety in larger, more diverse populations before approval. After marketing, the broad use over longer periods and in patients with various comorbidities can reveal issues not seen earlier, guiding label updates or other regulatory actions if needed.